ArticleCureus2024

Impact of Empagliflozin on the Outcomes of β-Thalassemia Major in Patients With Type 2 Diabetes Mellitus: The THALEMPA Observational Study.

Anas Ibraheem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.